Hu ML - Search Results

1

Association between single nucleotide polymorphisms of the transforming growth factor-β1 gene and overall survival in unresectable locally advanced non-small-cell lung cancer patients treated with radio(chemo)therapy in a Chinese population.

Xue SL, Zheng YH, Su HF, Deng X, Zhang XB, Zou CL, Hu ML, Xie CY. Xue SL, et al. Among authors: hu ml. Med Oncol. 2013 Jun;30(2):512. doi: 10.1007/s12032-013-0512-0. Epub 2013 Feb 23. Med Oncol. 2013. PMID: 23435990

2

A pilot study of combination intraperitoneal recombinant human endostatin and chemotherapy for refractory malignant ascites secondary to ovarian cancer.

Zhao J, Chen X, Zhang A, Xu F, Hu M, Xie C, Xue S. Zhao J, et al. Med Oncol. 2014 Apr;31(4):930. doi: 10.1007/s12032-014-0930-7. Epub 2014 Mar 22. Med Oncol. 2014. PMID: 24659268

3

Adjuvant combined systemic chemotherapy and intraperitoneal chemotherapy for locally advanced gastric cancer.

Xue SL, Su HF, Hu XQ, Deng X, Hu ML, Xie CY. Xue SL, et al. Among authors: hu xq, hu ml. Oncol Lett. 2012 Dec;4(6):1309-1314. doi: 10.3892/ol.2012.914. Epub 2012 Sep 13. Oncol Lett. 2012. PMID: 23205128 Free PMC article.

4

Intraperitoneal recombinant human endostatin combined with chemotherapy for refractory malignant ascites due to gastrointestinal cancer: a pilot study.

Xue SL, Deng X, Liu Y, Su HF, Hu ML, Xie CY. Xue SL, et al. Among authors: hu ml. Hepatogastroenterology. 2013 Jan-Feb;60(121):118-23. doi: 10.5754/hge12497. Hepatogastroenterology. 2013. PMID: 22784939

5

Dosimetric benefits of IMRT and VMAT in the treatment of middle thoracic esophageal cancer: is the conformal radiotherapy still an alternative option?

Wu Z, Xie C, Hu M, Han C, Yi J, Zhou Y, Yuan H, Jin X. Wu Z, et al. J Appl Clin Med Phys. 2014 May 8;15(3):93–101. doi: 10.1120/jacmp.v15i3.4641. J Appl Clin Med Phys. 2014. PMID: 24892336 Free PMC article.

6

Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma.

Jing Z, Nan KJ, Hu ML. Jing Z, et al. Among authors: hu ml. World J Gastroenterol. 2005 Apr 7;11(13):1910-6. doi: 10.3748/wjg.v11.i13.1910. World J Gastroenterol. 2005. PMID: 15800979 Free PMC article.

7

Developments and clinical experiences in collagenase chemonucleolysis for lumbar disc herniation: a narrative review.

Zhang H, Zhang C, Li L, Hu ML, Zhao JN, Zheng Z, Ding WF. Zhang H, et al. Among authors: hu ml. Front Med (Lausanne). 2025 Jan 8;11:1522568. doi: 10.3389/fmed.2024.1522568. eCollection 2024. Front Med (Lausanne). 2025. PMID: 39845813 Free PMC article. Review.

8

Chronic low-dose REV-ERBs agonist SR9009 mitigates constant light-induced weight gain and insulin resistance via adipogenesis modulation.

Yang MY, Lin HY, Chen YM, Hu ML, Chen IY, Yang CH. Yang MY, et al. Among authors: hu ml. Biomed J. 2025 Jan 10:100830. doi: 10.1016/j.bj.2025.100830. Online ahead of print. Biomed J. 2025. PMID: 39800061 Free article.

9

[Study on the association between different obesity metabolic phenotypes and carotid plaque].

Liu S, Miao XL, Wang QQ, Tang GM, Xie XL, Hu ML, Song ZP, Leng S. Liu S, et al. Among authors: hu ml. Zhonghua Xin Xue Guan Bing Za Zhi. 2024 Dec 24;52(12):1390-1396. doi: 10.3760/cma.j.cn112148-20241105-00671. Zhonghua Xin Xue Guan Bing Za Zhi. 2024. PMID: 39681441 Chinese.

10

Identification of novel inhibitors targeting PI3Kα via ensemble-based virtual screening method, biological evaluation and molecular dynamics simulation.

Zhang H, Qi HZ, Li YJ, Shi XY, Hu ML, Chen XL, Li Y. Zhang H, et al. Among authors: hu ml. J Comput Aided Mol Des. 2024 Nov 11;38(1):37. doi: 10.1007/s10822-024-00580-2. J Comput Aided Mol Des. 2024. PMID: 39528618

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

371 results

Search Page

Filters